From what I see on the chart of AXP, there's a neutral short-term trend playing out within a broader downtrend that's developed over the past quarter. Shares have fallen about -17% year-to-date from a 52-week high near $387, and now they're trading around $305-$306 in a consolidation phase over the last 30 days, posting a modest 1.7% gain. The price action is forming higher lows in what looks like an impulsive structure, but the inability to reclaim longer-term moving averages points to ongoing bearish pressure. One thing that stands out is the key upward-sloping weekly trendline from October 2023, which has acted as support on three occasions now—the current test near $300 is something I'm watching closely for potential bounces, as we've seen before.
Pivot analysis puts the classic pivot right at $302, which lines up neatly with the recent consolidation range. Immediate support is at S1 $291.48, with deeper levels down at S2 $280 and S3 $259. On the resistance side, it starts at R1 $312.97, then R2 $323.46, and R3 $345. These align well with the zones traders are focused on: $300 as that critical trendline support, and $310-$315 as a potential breakout area. In my view, a sustained move above $313 could open up targets around $340, while a break below $291 might quicken the pace toward those lower supports.
Momentum indicators are holding a balanced stance right now, but there are hints of bullish divergence emerging. The daily RSI (14) sits at 48.17, firmly neutral and steering clear of overbought or oversold territory. On the weekly chart, RSI is near 38—edging toward oversold—while forming higher lows relative to price, which is a classic bullish signal. The MACD (12,26) at -5.89 is flashing a buy signal, bolstered by divergences on both daily and weekly timeframes where momentum isn't keeping pace with the price declines. Stochastic %K (14,3,3) at 70.54 remains neutral, and CCI (20) at 80.93 indicates there's still room to the upside before hitting overbought levels.
The shorter-term moving averages are leaning bullish: EMA(10) at $300.93 (buy), SMA(20) at $300.14 (buy), and VWMA(20) at $300.04 (buy). That said, price is still trading below the longer-term averages—SMA(50) at $324.19 (sell), SMA(100) at $346.01 (sell), and SMA(200) at $335.39 (sell). This bearish setup across the key 50-, 100-, and 200-day MAs confirms the intermediate downtrend. I also checked this using Tickeron’s AI Screener to see how AXP stacks up against peers, and a crossover above the 50-day SMA would be a pivotal signal for any reversal.
Volume lately has been running below average, around 780K shares compared to the typical 3.8M, which fits with the subdued action during this consolidation. I've noticed demand picking up on those trendline tests, and volume spikes would be key to watch on any breakouts. With a beta of 1.30, AXP shows higher volatility than the broader market, which is typical for financial sector names.
In my own research, I turn to Tickeron’s AI Daily Buy/Sell Signals to analyze stocks like AXP. This tool uses artificial intelligence to dig through massive amounts of market data, technical indicators, and price patterns, delivering actionable buy or sell signals. It pulls from trend recognition, historical pattern matching, and momentum analysis to help spot entry and exit points, confirm trends, and support trading decisions—especially useful in volatile stretches. I find it reliable for validating chart setups and sharpening timing. If you're looking for real-time insights tied to the current market, checking out the AI Daily Buy/Sell Signals is part of my routine.
Overall, I'm keeping an eye on whether AXP holds above that $300 trendline support for any bullish continuation—a weekly close above $310-$315 could push toward $340-$360, and maybe even extensions to $380. On the flip side, a drop below $291 might test those deeper supports at $280. Key things to monitor include sustained bullish divergence in RSI, MACD crossovers, and volume pickup on moves toward R1 at $313. The short-term MAs could offer dynamic support, but reclaiming the 50-day SMA at $324 is crucial for any real trend shift.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for AXP crossed bearishly below the 50-day moving average on August 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXP as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AXP turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
AXP moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for AXP moved above the 200-day moving average on August 12, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXP advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
AXP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 276 cases where AXP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AXP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.618) is normal, around the industry mean (4.367). P/E Ratio (20.388) is within average values for comparable stocks, (17.143). Projected Growth (PEG Ratio) (1.565) is also within normal values, averaging (2.035). Dividend Yield (0.010) settles around the average of (0.070) among similar stocks. P/S Ratio (3.037) is also within normal values, averaging (5.973).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a financial conglomerate
Industry SavingsBanks